The Iranian Journal of Obstetrics, Gynecology and Infertility

The Iranian Journal of Obstetrics, Gynecology and Infertility

Postpartum Hemorrhage as the First Manifestation of Choriocarcinoma: A Case Report

Document Type : Case report

Authors
Zohreh Yousefi 1
Sedighe ghasemian 2
Farzaneh Rashidi Fakari 3
mohammad Bidar Farimani 4
1 Professor, Department of Obstetrics and Gynecology, Ovulation Dysfunction Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
2 Resident of Obstetrics and Gynecology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
3 Msc student of Midwifery, Mashhad Faculty of Nursing and Midwifery, Mashhad University of Medical Sciences, Mashhad, Iran.
4 Clinical Pathologist, Mashhad, Iran.
10.22038/ijogi.2014.2614
Abstract
Introduction: Vaginal bleeding is the common sign of clinical manifestation of late vaginal bleeding of postpartum and choriocarcinoma. Choriocarcinoma grows rapidly and metastases and damage vessels and result bleeding. We have described a case of postpartum hemorrhage with metastatic choriocarcinoma.
Case report: A 34 year old woman with vaginal bleeding after 45 days of vaginal delivery admitted and evaluation revealed choriocarcinoma. Because of multi organs metastasis, surgery and chemotherapy was done but the patient did not respond to treatment and died.
Conclusion: Regarding vaginal bleeding is the common sign of clinical manifestation of late postpartum hemorrhage and choriocarcinoma, it is recommended to be considered in differential diagnosis of choriocarcinoma
Keywords
chemotherapy
Choriocarcinoma
Gestational trophoblastic disease
Postpartum Hemorrhage
  1. Miller JM, Surwit EA, Hammond CB. Choriocarcinoma following term pregnancy. Obstet Gynecol 1979 Feb;53(2):207-12.
  2. Yousefi Z, Homaei F. [Gestaional trophoblastic disease with metastasis to kinidey:case report] [Article in Persian]. Iran J Obstet Gynecol Infertil 2005;8(3);152-7.
  3. Danihel L, Sokol L, Breitenecker G, Korbel H, Porubsky J, Liska J, et al. [Extrauterine choriocarcinoma-a rare form of gestational trophoblastic disease] [Article in Slovak]. Bratisel Lek Listy 1996 May;97(5):279-83.
  4. Nugent D, Hassadia A, Everard J, Hancock BW, Tidy JA. Postpartum choriocarcinoma presentation, management and survival. 2006 Oct;51(10):819-24.
  5. Tidy JA, Rustin GJ, Newlands ES, Foskett M, Fuller S, Short D, et al. Presentation and management of choriocarcinoma after nonmolar pregnancy. Br J Obstet Gynecol 1995 Sep;102(9):715-9.
  6. Lurain JR, Brewer JI. Treatment of high-risk gestational trophoblastic disease with methotrexate, actinomaycin and cyclophosphamide chemotherapy. Obstet Gynecol 1985 Jun;65(6):830-6.
  7. Dobson LS, Gillespie AM, Coleman RE, Hancock BW. The presentation and management of post-partum choriocarcinoma. Br J Cancer 1999 Mar;79(0-10):1531-3.
  8. Balagopal P, Pandey M, Chandramohan K, Somanathan T, Kumar A. Unusual presentation of choriocarcinoma. World J Surg Oncol 2003 Apr 17;1(1):4.
  9. Flam F. Choriocarcinoma in the term placentas, a difficult diagnosis. Eur J Gynecol Oncol 1996;17(6):510-1.
  10. Feltmate CM, Genest DR, Wise L, Bernstein MR, Goldstein DP, Berkowitz RS. Placental site trophoblastic tumor: a 17-year experience at the new England Trophoblastic Disease Center. Gynecol Oncol 2001 Sep;82(3):415-9.
  11. Ma Y, Xiang Y, Wan XR, Chen Y, Feng FZ, Lei CZ, et al. The prognostic analysis of 123 postpartum choriocarcinoma cases. Int J Gynecol Cancer 2008 Sep-Oct;18(5):1097-101.
  12. Roy JS, Wasik S, Begum A, Hossen M, Hossain F. Metastatic choriocarcinoma following live birth – a rare presentation. Bangabandhu Sheikh Mujib Med Univ J 2011;4(2):116-8.
  13. Kumari S, Chaudhuri P, Aich M. Choriocarcinomafollowing term live birth-case report. RCOG World Congress 2013. Liverpool UK, 24-26 June 2013. Available at: http://epostersonline.s3.amazonaws.com/rcog2013/rcog2013.3130238.NORMAL.pdf
  14. Ryu JH, Choi CH, Kim TJ, Lee JW, Kim BG, Bae DS. Chemo-resistant choriocarcinoma metastatic to colon cured by low-anterior resection. J Gynecol Oncol 2011 Sep;22(3):203-6.